Kohjin Bio Co., Ltd.

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3283630006
JPY
880.00
-5 (-0.56%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
No of Months
12
12
12
12
12
Operating Income
4,939.00
5,206.00
4,770.00
4,742.00
3,947.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
Net Sales
4,939.00
5,206.00
4,770.00
4,742.00
3,947.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
Operating Expenses
38.00
30.00
22.00
32.00
38.00
General and Administration Expenses
1,264.00
1,206.00
1,043.00
1,025.00
934.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
Total Expenditure
4,597.00
4,215.00
4,173.00
3,475.00
2,977.00
Operating Profit (PBDIT) excl Other Income
341.00
991.00
596.00
1,267.00
969.00
Other Income
18.00
105.00
61.00
9.00
-11.00
Operating Profit (PBDIT)
756.00
1,457.00
958.00
1,444.00
1,136.00
Interest
38.00
30.00
22.00
32.00
38.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
Depreciation
396.00
360.00
299.00
167.00
179.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
332.00
1,015.00
635.00
1,244.00
922.00
Provision for Tax
81.00
220.00
250.00
414.00
334.00
Profit After Tax
251.00
794.00
384.00
829.00
587.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
49.11
157.56
76.77
165.46
117.18
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is -5.13% vs 9.14% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -65.54% vs 66.07% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 26.55% vs 31.48% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -68.42% vs 106.44% in Mar 2025

Compare Profit and Loss Results of Kohjin Bio Co., Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
4,939.00
0
4,939.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
4,939.00
0
4,939.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
0.00
0
0.00
0%
Operating Expenses
38.00
0
38.00
0%
General and Administration Expenses
1,264.00
0
1,264.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
4,597.00
0
4,597.00
0%
Operating Profit (PBDIT) excl Other Income
341.00
0.00
341.00
0%
Other Income
18.00
0
18.00
0%
Operating Profit (PBDIT)
756.00
0
756.00
0%
Interest
38.00
0
38.00
0%
Profit before Depriciation and Tax
0.00
0
0.00
0%
Depreciation
396.00
0
396.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
332.00
0
332.00
0%
Provision for Tax
81.00
0
81.00
0%
Profit After Tax
251.00
0
251.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
0.00
0
0.00
0%
Profit Available for appropriations
0.00
0
0.00
0%
Appropriations
0.00
0
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
49.1077
0
49.11
0%
Profit And Loss - Net Sales
Net Sales 4,939.02 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is -5.13% vs 9.14% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 341.54 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is -65.54% vs 66.07% in Mar 2025

Profit And Loss - Interest
Interest 38.05 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is 26.55% vs 31.48% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 251.02 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is -68.42% vs 106.44% in Mar 2025